Latest news with #Alpharetta
Associated Press
2 days ago
- Sport
- Associated Press
Atlanta National Pickleball Club Welcomes Legendary Coach Chris Wolfe as Director
07/28/2025, Alpharetta, GA // KISS PR Brand Story PressWire // Atlanta National Pickleball Club has officially named Chris Wolfe, legendary coach and co-founder of the PPA Atlanta Open, as its new director of pickleball. The appointment is a bold step forward as the club strengthens its standing as the premier destination for both high-level competition and community-focused play in Georgia. With Wolfe at the helm, Atlanta National Pickleball Club gains a Certified Master Instructor and one of Atlanta's most respected pickleball leaders. His contributions to the sport are far-reaching, from co-creating the Atlanta Open in 2017 to launching one of the city's earliest leagues and coaching extensively across the Metro Atlanta area. 'I'm so excited to announce I'm the Director of Pickleball at the new Atlanta National Pickleball Club in Alpharetta!' Wolfe shared. 'Pickleball has been a huge part of my life, and I look forward to building something truly special with this incredible club.' As pickleball continues to surge in popularity across Georgia, the Atlanta National Pickleball Club is raising the bar with the appointment of Wolfe as its new director of pickleball. He brings decades of experience and impeccable timing to a club poised to become the Southeast's premier indoor pickleball destination. Known for his ability to connect with players of all levels, Wolfe will lead the club's programs with passion, purpose, and expertise. Through personalized instruction and dynamic lessons, he will help players sharpen their skills while cultivating a culture where energy, talent, and community thrive. Wolfe's influence has already left a mark on both regional and national pickleball, with deep roots in Atlanta's earliest organized leagues and tournament development. His efforts helped lay the foundation for consistent league play, structured pickleball lessons , and player development that didn't previously exist. His guidance has turned beginners into competitors and sharpened veterans, often on the same indoor pickleball courts that set today's training standard. 'Sharing my love for this sport and helping players grow has always been my passion,' Wolfe said. 'I've known many of you for years and recently met even more at our booth during the Atlanta Pickleball Championships. I'm excited to continue building this incredible community.' Under Wolfe's leadership, the Alpharetta-based pickleball club is becoming far more than a recreational facility. With premium indoor pickleball courts, tailored instruction, and inclusive leagues, ANPC provides a full pickleball lifestyle experience. Players can expect expert coaching, along with both open play sessions and structured playing opportunities, designed for all skill levels. To learn more about membership, upcoming events, or pickleball lessons at Atlanta National Pickleball Club, visit About Atlanta National Pickleball Club Atlanta National Pickleball Club is Georgia's top destination for indoor pickleball. ANPC will showcase 18 beautiful indoor courts with state of the art lighting and tournament quality spacing between courts. The club will also have luxurious locker rooms with saunas and showers, a fully equipped fitness floor, and various additional wellness and spa services. Finally you'll also enjoy a full service restaurant on the main level, as well as a massive mezzanine overlooking all 18 courts, which will feature a full bar, private & corporate event space, and large flexible work/play/socialize space for the members. ANPC offers a high-energy environment where players can grow, compete, and connect. Whether one is new to the game or an aspiring pro, the club provides more than a place to play. It is a community built for those who love the sport and want to be part of something bigger. ANPC is also planning a future outdoor phase, to include outdoor courts, dining, and concert/event space to further enhance the member experience. ### Media Contact Atlanta National Pickleball Club Phone: (770) 675-4633 Address: 10800 Davis Dr, Alpharetta, GA 30009 Website: newsroom: Source published by Submit Press Release >> Atlanta National Pickleball Club Welcomes Legendary Coach Chris Wolfe as Director
Yahoo
21-07-2025
- Business
- Yahoo
Premier Anesthesia Partners with Salina Regional Health Center to Power Next Phase of Surgical Excellence
Collaboration to Optimize Anesthesia Services Through Tailored Solutions ALPHARETTA, Ga., July 21, 2025--(BUSINESS WIRE)--Premier Anesthesia, a leading privately held single-specialty anesthesia practice management firm, today announced a strategic partnership with Salina Regional Health Center (SRHC), the principal hospital of a highly regarded health system and a designated Level III Trauma Center serving north-central Kansas. Through this collaboration, Premier Anesthesia will provide tailored anesthesia consulting and practice management services to support SRHC's transition to a hospital-employed anesthesia model. In this capacity, it will oversee daily operations of the hospital-based anesthesia team committed to maintaining clinical excellence, fostering workforce stability and helping ensure seamless continuity throughout the transition. Premier Anesthesia also will provide strategic guidance on surgical operations to help optimize operating room utilization and overall efficiency. "We are privileged to partner with Salina Regional Health Center at this pivotal moment," said Preston Smith, president, Premier Anesthesia. "This collaboration goes beyond operational change by establishing a resilient framework for sustained excellence in anesthesia services. In line with Salina Regional's goals, we are helping build a scalable, high-performing infrastructure that benefits existing patients and positions the health system for future advancement." Salina Regional Health Center is widely recognized for its compassionate patient care and use of advanced technology, while remaining dedicated to delivering superior care that promotes rapid recovery and long-term well-being. This partnership is timely as the health system aims to expand and enhance its surgical service lines while preserving high standards in anesthesia. "Our alliance with Premier Anesthesia will increase access and strengthen our ability to serve patients," added Dr. Rob Freelove, chief medical officer, Salina Regional Health Center. "With comprehensive oversight of scheduling and care delivery, we expect increased efficiency and a seamless patient experience, further supporting our commitment to timely, integrated care across all service lines." This partnership demonstrates a shared commitment to excellence in clinical quality, operations and patient outcomes. It also reflects an evolving model in which anesthesia practice management organizations partner with hospitals to facilitate provider employment transitions and ensure robust program administration. ABOUT SALINA REGIONAL HEALTH CENTER Salina Regional Health Center is a full-service acute care hospital dedicated to delivering outstanding health care quality and patient outcomes across north central Kansas and beyond. Affiliated with three Critical Access Hospitals located in Abilene, Concordia, and Lindsborg, Salina Regional forms the cornerstone of an integrated health system that includes more than 20 primary care and specialty clinics that provide outreach services in communities across the area. With a team of more than 2,550 skilled professionals – equipped with the latest medical technology – the system stands at the forefront of health care in the region providing a continuum of medical care and advanced, lifesaving services. For more information, please visit ABOUT PREMIER ANESTHESIA Premier Anesthesia is one of the nation's largest privately held anesthesia management companies. Solely focused on building and managing the best anesthesia teams in the industry, its leadership brings extensive experience and expertise in hospital-based physician staffing, recruiting and management, helping hospital and healthcare facilities across the country achieve superior clinical, business and patient outcomes. Premier Anesthesia is part of the Jackson Healthcare® family of companies. Learn more at View source version on Contacts For More Information, Contact: media@ Sign in to access your portfolio
Associated Press
17-07-2025
- Business
- Associated Press
Clearside Biomedical Announces Plan to Explore Strategic Alternatives to Advance its Proprietary Suprachoroidal Space (SCS®) Delivery Platform and Promising Ophthalmology Pipeline
- Proven In-Office, Repeatable, Non-Surgical Procedure for the Targeted Delivery of a Wide Variety of Therapies for Serious Retinal Diseases - - CLS-AX Phase 3-Ready Asset with Global Investigator Support and FDA Alignment on Pivotal Trial Program in wet AMD - - Validated Delivery Platform with Five Commercial and Late-Stage Development Suprachoroidal Licensing Collaborations - ALPHARETTA, Ga., July 17, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), today announced plans to explore a full range of strategic alternatives to advance its SCS platform and drug development pipeline to maximize stockholder value. The Company has retained Piper Sandler, a leading investment bank with substantial experience in the biotechnology industry, to support it with the strategic evaluation process. Strategic alternatives under consideration include the sale, license, monetization and/or divestiture of one or more of the Company's assets and technologies, collaboration, partnership, merger, acquisition, joint ventures, or other strategic transactions. 'We strongly believe that our proprietary suprachoroidal delivery platform provides an effective and reliable way to target challenging retinal diseases that need longer lasting treatments,' said George Lasezkay, PharmD, JD, President and Chief Executive Officer. 'Our SCS Microinjector® enables a proven in-office, repeatable, non-surgical procedure for the targeted delivery of a wide variety of therapies to the macula, retina, and choroid. Based on our retinal expertise and intellectual property, we delivered the first commercial product using our SCS platform, which is now approved and commercialized in the U.S., approved in Singapore and Australia, and is currently under regulatory review in China and Canada.' Dr. Lasezkay further stated, 'We have successfully produced positive and highly competitive Phase 2b clinical data for CLS-AX for the treatment of wet AMD. We are proud of the fact that the CLS-AX ODYSSEY Phase 2b trial is the only TKI clinical trial to date to achieve positive safety and efficacy results from multiple TKI dosing in wet AMD patients. Further, in February 2025, we conducted a successful end of Phase 2 meeting with the FDA through which we gained alignment on a Phase 3 development plan for CLS-AX in wet AMD. In addition, our clinical development collaboration partners continue to make progress in advancing their later-stage suprachoroidal clinical programs utilizing our SCS Microinjector in various ophthalmic disorders.' Dr. Lasezkay continued, 'Clearside's innovative and pioneering achievements demonstrating the safety, simplicity and effectiveness of delivering drugs to the suprachoroidal space are the direct result of the many years of significant contributions by the current Clearside team and many of our past employees. I am proud of and grateful for their hard work and dedicated commitment to improving the lives of patients suffering from the burden of disabling, blinding diseases.' 'Given the current unpredictable economic environment and challenging fundraising conditions in the biopharmaceutical industry, we are taking the necessary next steps to evaluate strategic alternatives for the Company. In order to facilitate this process and conserve cash, while continuing our support of the Company's SCS Microinjector® licensees, all Clearside employees, including the Chief Executive Officer, Chief Financial Officer, and Chief Medical Officer, will transition into consulting roles with the Company this week. In addition, we will pause all internal research and development programs during this process,' concluded Dr. Lasezkay. No agreement providing for any strategic transaction has been reached and there can be no assurance that this process will result in any such transaction. Clearside has not set a timetable for the strategic review process. Clearside does not intend to provide updates until the Board approves a specific action or otherwise determines that disclosure is appropriate or required. Company Highlights SCS Injection Platform: Internal Pipeline - CLS-AX Program: Internal Pipeline – Preclinical Small Molecule Programs: External Licensing Agreements: About Clearside Biomedical, Inc. Clearside Biomedical, Inc. is a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®) to improve patient outcomes. Clearside's SCS injection platform, utilizing the Company's patented SCS Microinjector®, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases. Clearside is developing its own pipeline of small molecule product candidates for administration via its SCS Microinjector. The Company's lead program, CLS-AX (axitinib injectable suspension), is in development for the treatment of neovascular age-related macular degeneration (wet AMD). Planning for a Phase 3 program is underway. In addition, Clearside is evaluating various small molecules for the potential long-acting treatment of geographic atrophy (GA). Clearside developed and gained approval for its first product, XIPERE®(triamcinolone acetonide injectable suspension) for suprachoroidal use, which is available in the U.S. through a commercial partner. Clearside also strategically partners its SCS injection platform with companies utilizing other ophthalmic therapeutic innovations. For more information, please visit or follow us on LinkedIn and X. Cautionary Note Regarding Forward-Looking Statements Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements may be identified by words such as 'believe', 'expect', 'may', 'plan', 'potential', 'will', and similar expressions, and are based on Clearside's current beliefs and expectations. These forward-looking statements include statements regarding the clinical development of CLS-AX, including the planned Phase 3 trial design, the potential benefits of CLS-AX, Clearside's suprachoroidal delivery technology and Clearside's SCS Microinjector®, and Clearside's pursuit of strategic alternatives and the entry into or completion of any strategic alternative transaction. These statements involve risks and uncertainties that could cause actual results to differ materially from those reflected in such statements. Risks and uncertainties that may cause actual results to differ materially include uncertainties inherent in the conduct of clinical trials, Clearside's reliance on third parties over which it may not always have full control, Clearside's ability to raise additional capital, and other risks and uncertainties that are described in Clearside's Annual Report on Form 10-K for the year ended December 31, 2024, filed with the U.S. Securities and Exchange Commission (SEC) on March 27, 2025 and Clearside's other Periodic Reports filed with the SEC. Any forward-looking statements speak only as of the date of this press release and are based on information available to Clearside as of the date of this release, and Clearside assumes no obligation to, and does not intend to, update any forward-looking statements, whether as a result of new information, future events or otherwise. Investor and Media Contacts: Jenny Kobin Remy Bernarda [email protected] Source: Clearside Biomedical, Inc.
Yahoo
16-07-2025
- Business
- Yahoo
Orbit Analytics Introduces Websheets; A Cloud-Native, AI-Powered Spreadsheet Tool for Oracle and Cloud Data
Next-Gen Solution Combines User-Friendly Spreadsheet Interface with Live Oracle Data, With a Time Savings of Up to 35% on Data Analysis Tasks ALPHARETTA, Ga., July 16, 2025 /PRNewswire/ -- Orbit Analytics, an AI-powered leader of advanced business intelligence solutions tailored for enterprise ERP environments, today announced the release of AI powered Websheets, a powerful new enterprise spreadsheet interface that delivers real-time, cloud-native data directly within a familiar format. Built for finance, operations, and executive teams, Websheets combines the comfort of Excel with the governance, performance, and collaboration today's enterprises require. Traditional spreadsheet workflows relying on manual exports, file-based sharing, and periodic refresh cycles no longer meet the demands of today's data-driven enterprises. Finance teams endure multi-day close processes, business analysts wrestle with stale KPIs, and operations stakeholders navigate siloed data that delays critical decisions. Orbit Websheets eliminates these constraints by delivering a fully cloud-native spreadsheet platform that connects to ERP applications along with Data Warehouses such as Oracle Autonomous Data Warehouse (ADW), Snowflake, BigQuery, Databricks, and Redshift in one click. "With Websheets, we've combined the familiarity of Excel and spreadsheets with the power of real-time, multi-data source analytics, giving enterprise users a seamless way to explore, analyze, and move through their data," said Rupesh Sharma, CEO and Co-founder of Orbit Analytics. "Websheets is combining a generally accepted interface with the accuracy of live data, with built in security and segmented data access across the organization. This is a unique innovation among business intelligence platforms and perfectly aligns with our users' need to focus on decisions, not data wrangling." Unlike traditional spreadsheets, which operate as static files, Websheets connects directly to live data sources via secure APIs, enabling real-time updates, multi-user collaboration, and governed access based on user roles. For example, finance teams can reconcile accounts and close books in hours instead of days. Operations leaders can monitor supply chain KPIs with up-to-the-minute visibility, while executives can track performance with live dashboards that reflect the current state of the business, with trustworthy real-time data, while eliminating the need for manual exports, broken formulas, and stale data. Users can build reports, perform analysis at rapid speed, and create simple to use dashboards with real-time without relying on IT or risking out of date data across multiple segmented platforms. "Websheets offers much more than a simple cloud-based tool," said Ravi Jasti, CTO and Co-founder of Orbit Analytics. "Websheets combines the comfortable view of a spreadsheet with the deep technical rigor needed from an enterprise reporting platform. Our solution increases overall efficiency, with a time savings of up to 35% on data analysis tasks. We've embedded real-time cloud querying and role-based security, so every data point is audit-ready, traceable, and instantly actionable." Orbit Websheets includes several advanced capabilities that make enterprise reporting seamless and intuitive. It offers live cloud connectivity with an Excel-compatible interface, supporting familiar features like pivot tables, formulas, conditional formatting, and charts, all in a modern, browser-based environment. Built-in AI insights enable organizational trend detection, forecasting, and anomaly alerts. It also offers enterprise collaboration features such as multi-user editing, comment threads, audit trails, and template sharing with granular permissions to help teams work together securely and efficiently. The launch of Websheets reinforces Orbit's commitment to solving the typical fragmented reporting environment for enterprise ERP users. As more organizations modernize their analytics stacks, Websheets provides a workspace that enables business users to go from raw data to real-time decisions as fast as they need them. Orbit Analytics has been helping enterprises simplify reporting and analytics since 2006, with a focus on secure, scalable solutions built for the complexity of Oracle ERP environments. Founded by former Oracle engineers, the company supports more than 175,000 users worldwide and integrates with over 200 enterprise systems. You can learn more about Websheets here: About Orbit AnalyticsOrbit Analytics is an AI-powered business intelligence and data analytics solutions company with products designed to empower organizations to unlock the full potential of their data. Seamlessly integrating with all ERP systems, cloud data platforms, and essential business applications, Orbit Analytics delivers real-time access to unified data from diverse sources via its core products GL Sense and Data Pipelines. This enables business users to effortlessly craft interactive reports, dynamic dashboards, and insightful visualizations in ways not possible through native ERP applications. Orbit's solutions accelerate report migration from Oracle ERP systems and other legacy tools, making it easier than ever to modernize analytics workflows. By transforming raw data into actionable insights, Orbit Analytics empowers industries to make informed decisions, enhance operational efficiency, and drive exceptional business performance. With Orbit Analytics, an organization's data becomes a strategic asset, not a cost center, fueling innovation and driving decision making in a modern landscape. Visit to learn more. Press Contact Kyle PorterEVP, Virgo PRorbit@ View original content: SOURCE Orbit Analytics Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
10-07-2025
- Business
- Yahoo
Mid-Rivers Communications Elevates Customer Engagement With GOCare's Digital Experience Suite
GOCare integration with Calix, NISC, and TalkDesk streamlines operations and customer care ALPHARETTA, Ga., July 10, 2025 /PRNewswire/ -- GOCare, a leading SaaS provider of digital customer experience solutions for broadband service providers (BSPs), announces a strategic partnership with Mid-Rivers Communications. The collaboration focuses on improving subscriber communications—particularly around maintenance and service-impacting events during ongoing fiber network expansion—while also integrating advanced NPS® and CSAT tools to support voice-of-the-customer initiatives. Mid-Rivers' rollout of the GOCare Digital Experience Platform marks a bold step forward in transforming how the provider engages with customers. This move reflects the company's ongoing commitment to delivering an exceptional, modern customer experience, empowering subscribers with more control and easier ways to provide real-time feedback to Mid-Rivers that drive a proactive customer experience. By deeply integrating GOCare into Mid-Rivers' operations—including NISC billing system, Calix cloud tools, and TalkDesk voice/UCaaS platform—Mid-Rivers will provide customers with real-time, accurate data across every touchpoint. From intelligent self-service to proactive communications, GOCare enables seamless, digital engagement. "Our legacy is rooted in innovation and value. But it's no longer enough to simply build a great network—we must also make it easy and enjoyable to do business with us," said Marlo Holzworth, Chief Customer Officer at Mid-Rivers. "We want to meet our customers where they are, get their feedback, update them quickly on our operations, and GOCare is central to delivering on that promise." Mike Roddy, CEO and Co-Founder of GOCare, added, "We welcome Mid-Rivers as our latest broadband cooperative client-partner. Their commitment to delivering a better customer experience by embracing digital channels reflects a forward-thinking approach we admire. By enabling clear communication and engaging subscribers on their terms, Mid-Rivers is well-positioned to reduce friction and provide a more responsive, modern service experience." About GOCareGOCare is a trusted digital experience platform for broadband service providers, driving customer satisfaction and operational efficiency. Our innovative SaaS solution integrates seamlessly with existing operator technology stacks—including billing, network operations, IT, and marketing platforms—empowering providers to deliver proactive notifications and personalized interactions through two-way SMS, social media, web chat, and email. Founded by telecom veterans, GOCare's "For Operators, By Operators" ethos underscores our deep understanding of the broadband industry's challenges. We are committed to helping operators transform the customer experience, making it easier for subscribers to connect, communicate, and engage at every touchpoint. Serving over 30 broadband operators and powering more than 30 million monthly digital interactions, GOCare reduces call volumes, cuts operational costs, accelerates payments, and boosts customer satisfaction metrics. Learn more at and follow us on LinkedIn. About Mid-Rivers CommunicationsMid-Rivers Communications is a member-owned communications cooperative providing broadband and voice services to 30,000 square miles of Eastern and Central Montana. The Mid-Rivers mission is to provide essential high-quality telecommunications services with personal customer care at the lowest cost consistent with sound business practices. At Mid-Rivers, it's the people who matter. View original content to download multimedia: SOURCE GOCare Sign in to access your portfolio
